Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Ann Rheum Dis. 2021 Mar 22;80(8):989–996. doi: 10.1136/annrheumdis-2020-219682

Table 1.

Characteristics of the Pre-Rheumatoid Arthritis Cases and Controls in the Department of Defense Serum Biorepository Study Sample

Characteristics Cases
(N=291)
Controls
(N=292)
All
(N=583)
Age
 1st Blood Draw, Mean (SD) 32.6 (8.1) 29.7 (7.9) 31.2 (8.1)
 2nd Blood Draw, Mean (SD) 34.3 (8.3) 33.5 (7.5) 33.9 (7.9)
Male, N (%) 140 (48.1) 140 (47.9) 280 (48)
Race, N (%)
 White 155 (53.3) 153 (52.4) 308 (52.8)
 Black 76 (26.1) 80 (27.4) 156 (26.8)
 Other 60 (20.6) 59 (20.2) 119 (20.4)
Smoking Status, N (%)
 Ever 91 (31.3) 74 (25.3) 165 (28.3)
 Never 191 (65.6) 168 (57.5) 359 (61.6)
 Missing 9 (3.1) 50 (17.1) 59 (10.1)
BMI Category, N (%)
 Underweight 0 (0) 1 (0.3) 1 (0.2)
 Normal 93 (32) 45 (15.4) 138 (23.7)
 Overweight 141 (48.5) 76 (26.0) 217 (37.2)
 Obese 52 (17.9) 26 (8.9) 78 (13.4)
 Missing 5 (1.72) 144 (49.3) 149 (25.6)
RA Features
Age at Diagnosis, Mean (SD) 35.3 (8.21)
Seropositive Status, N (%)
 At 1st Blood Draw
  Seropositive 165 (58.1)
  Seronegative 82 (28.9)
  Missing 37 (13.0)
 At 2nd Blood Draw
  Seropositive 208 (72.5)
  Seronegative 52 (18.1)
  Missing 27 (9.41)
 Ever*
  Seropositive 235 (80.8)
  Seronegative 56 (19.2)
Years to RA Diagnosis, Mean (SD)
 From 1st Blood Draw 2.7 (1.6)
 From 2nd Blood Draw 1.0 (0.9)
*

Seropositivity in subsequent analyses based on ever ant-CCP or RF seropositive in medical records or anti-CCP or RF testing on stored samples.